These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 31417928)
21. Discharge Delays and Costs Associated With Outpatient Parenteral Antimicrobial Therapy for High-Priced Antibiotics. Bianchini ML; Kenney RM; Lentz R; Zervos M; Malhotra M; Davis SL Clin Infect Dis; 2020 Oct; 71(7):e88-e93. PubMed ID: 31665269 [TBL] [Abstract][Full Text] [Related]
22. Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections. Fanucchi LC; Murphy SM; Surratt H; Kapadia SN; Walsh SL; Grubbs JA; Thornton AC; Nuzzo P; Lofwall MR Ther Adv Infect Dis; 2022; 9():20499361221108005. PubMed ID: 35847566 [TBL] [Abstract][Full Text] [Related]
23. Outpatient parenteral antimicrobial therapy (OPAT) across the world: a comparative analysis-what lessons can we learn? Reidy P; Breslin T; Muldoon E JAC Antimicrob Resist; 2024 Aug; 6(4):dlae111. PubMed ID: 39035018 [TBL] [Abstract][Full Text] [Related]
24. Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis. Bradley JS; Behrendt CE; Arrieta AC; Harrison CJ; Loeffler AM; Iaconis JP; Wald ER Pediatr Infect Dis J; 2001 Jan; 20(1):19-24. PubMed ID: 11176562 [TBL] [Abstract][Full Text] [Related]
25. Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin. Nathwani D J Antimicrob Chemother; 2009 Sep; 64(3):447-53. PubMed ID: 19584105 [TBL] [Abstract][Full Text] [Related]
27. Inpatient Antibiotic Costs Associated With Switching From Vancomycin to Daptomycin for Outpatient Parenteral Antibiotic Therapy. Beardsley J; Patel S; Cook C; Pierce B; Johnson J; Ohl C; Luther V Hosp Pharm; 2022 Feb; 57(1):17-19. PubMed ID: 35521017 [No Abstract] [Full Text] [Related]
28. Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers. Hassanzai M; Adanç F; Koch BCP; Verkaik NJ; van Oldenrijk J; de Bruin JL; de Winter BCM; van Onzenoort HAW Ther Adv Infect Dis; 2023; 10():20499361231214901. PubMed ID: 38127471 [TBL] [Abstract][Full Text] [Related]
29. Cost minimization analysis of outpatient parenteral/oral antibiotic therapy at a trauma hospital: Public health system. Loesch GH; Cruz JAW; Gasparetto J; Oliveira DDS; Telles JP; Tuon FF Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1445-1450. PubMed ID: 33618784 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective. Bastug A; Oksuz E; Kazancioglu S; Malhan S; Ozbay BO; Bodur H Int J Clin Pract; 2021 Jun; 75(6):e14147. PubMed ID: 33709495 [TBL] [Abstract][Full Text] [Related]
31. Optimization of a model of out-of-hospital antibiotic therapy (OPAT) in a Belgian university hospital resulting in a proposal for national implementation. Ravelingien T; Buyle F; Deryckere S; Sermijn E; Debrauwere M; Verplancke K; Callens S; Commeyne S; Pattyn C; Vogelaers D Acta Clin Belg; 2016 Oct; 71(5):297-302. PubMed ID: 27203290 [TBL] [Abstract][Full Text] [Related]
33. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore. Chan M; Ooi CK; Wong J; Zhong L; Lye D BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717 [TBL] [Abstract][Full Text] [Related]
34. OPAT: proof of concept in a peripheral Belgian hospital after review of the literature. Smismans A; Vantrappen A; Verbiest F; Indevuyst C; Van den Poel B; von Winckelmann S; Peeters A; Ombelet S; Lybeert P; Heremans A; Frans E; Ho E; Frans J Acta Clin Belg; 2018 Aug; 73(4):257-267. PubMed ID: 29385901 [TBL] [Abstract][Full Text] [Related]
35. Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care. Yang A; Fung R; Brunton J; Dresser L Can J Infect Dis Med Microbiol; 2013; 24(2):74-8. PubMed ID: 24421805 [TBL] [Abstract][Full Text] [Related]
36. Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates? Steffens E; Quintens C; Derdelinckx I; Peetermans WE; Van Eldere J; Spriet I; Schuermans A Infection; 2019 Apr; 47(2):169-181. PubMed ID: 30443780 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of telemedicine in outpatient parenteral antimicrobial therapy (Tele-OPAT): A systematic review. Durojaiye OC; Jibril I; Kritsotakis EI J Telemed Telecare; 2024 Sep; 30(8):1230-1237. PubMed ID: 36221964 [TBL] [Abstract][Full Text] [Related]
38. Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement. Patel S; Abrahamson E; Goldring S; Green H; Wickens H; Laundy M J Antimicrob Chemother; 2015 Feb; 70(2):360-73. PubMed ID: 25331058 [TBL] [Abstract][Full Text] [Related]